Anika Therapeutics, Inc. — Director's Dealing 2012

Apr 23, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANIKA THERAPEUTICS INC (ANIK)
CIK: 0000898437
Period of Report: 2012-02-16

Reporting Person: BOWER JOSEPH I (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-16	Common Stock	M	11800	$1.05	Acquired	124379	Direct

Footnotes

F1: Exercise of stock options granted on March 21, 2002 which expire according to their terms on March 21, 2012.